Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00170703 · ClinicalTrials.gov registry record · Phase 1
Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.
A Phase 1 study of Stroke and Broca's Aphasia, sponsored by Northstar Neuroscience.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 2
- Study locations
NCT00170703: Completed Phase 1 study of Stroke and Broca's Aphasia, sponsored by Northstar Neuroscience.
NCT00170703 is a Phase 1 study of Stroke and Broca's Aphasia that has completed, run by Northstar Neuroscience. The registered enrollment target is 8 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00170703, a Phase 1 study of Stroke and Broca's Aphasia, has completed, sponsored by Northstar Neuroscience.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this feasibility study is to evaluate the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with speech-language rehabilitation activities to enhance recovery in study subjects suffering from Broca's aphasia (the inability to speak or to organize the muscular movements for speech), following a stroke.
Conditions Studied
Interventions
- DEVICE Cortical Electrical Stimulation
Study Locations (2)
Illinois
- Rehabilitation Institute of Chicago - Chicago
- Univ. of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2004-12 |
| Est. Completion | 2007-09 |
| Phase | Phase 1 |
What the finished NCT00170703 record still lists
NCT00170703 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Cortical Electrical Stimulation is the first listed.
NCT00170703 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00170703 about?
NCT00170703 is a clinical study titled "Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.". The primary objective of this feasibility study is to evaluate the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with speech-language rehabilitation activities to enhance recovery in study subjects suffering from Broca's aphasia (the inability ...
What is the current status of trial NCT00170703?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2004-12. Estimated completion is 2007-09.
What conditions does trial NCT00170703 study?
This clinical trial studies the following conditions: Stroke, Broca's Aphasia.
What interventions are being tested in trial NCT00170703?
The interventions under investigation include: Cortical Electrical Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00170703?
This trial is sponsored by Northstar Neuroscience, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00170703 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00170703's enrollment target sits among peer trials
8 427th of 454 higher than 26 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
Hybrid Robot+FES Stroke Rehabilitation
RECRUITING · Phase 1
-
Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
RECRUITING · Phase 1
-
Facilitating Neuroplastic Changes of Acute Stroke Survivors
RECRUITING · Phase 1
-
Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
RECRUITING · Phase 1
-
Accelerated rTMS vs. Sham for Stroke Apathy
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia